Navigation Links
CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
Date:5/16/2008

ROM OPERATIONS (2,085,098) (2,012,605)

LOSS ON DERIVATIVE INSTRUMENTS (1,160,937) (447,356)

INTEREST INCOME 157,256 77,114

INTEREST EXPENSE (121,515) (341,038)

NET LOSS BEFORE INCOME TAXES 3,210,294) (2,723,885)

INCOME TAX PROVISION - -

NET LOSS $(3,210,294) $(2,723,885)

DIVIDENDS (424,815) -

NET LOSS AVAILABLE TO COMMON

SHAREHOLDERS $(3,635,109) $(2,723,885)

NET LOSS PER COMMON SHARE (BASIC) $(0.03) $(0.03)

NET LOSS PER COMMON SHARE (DILUTED) $(0.03) $(0.03)

WEIGHTED AVERAGE COMMON

SHARES OUTSTANDING 116,312,378 83,836,076

CEL-SCI CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

Six Months Ended

March 31,

2008 2007

REVENUE:

Grant revenue $- $31,779

Rent income 1,530 12,895

Other income - 841

Total Revenue 1,530 45,515

EXPENSES:

Research and development, excluding

depreciation of $97,856 and

$41,794 included below 2,066,029 1,185,023

Depreciation and amortization 133,468 84,158'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
4. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
5. RediStat Corporation Partners With ALERT FM for Disaster-Proof Emergency Communications
6. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008
7. Diagnostic Health Corporation Names Robert E. Gontarek as COO
8. AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER(R) Vascular Plug III
9. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
10. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
11. CRH Medical Corporation opens Center in New York

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...s Southeastern Division has launched a new website...c instruments they need. The website is designed ...ge variety of the top brands of ophthalmic equipme...es the company to offer ophthalmic instruments at ...of products they offer, they can provide customers...
(Date:11/22/2009)...owth has now been found to be responsible for the ...characterize one of the most severe forms of sinus...s. The finding gives scientists a new target for d...e disease, which typically resists all current tre...ion and swelling of the nasal passages, is a commo...
(Date:11/22/2009)...ical Center is among 10 institutions selected by t...ion over five years as part of the Inner City Asth...s funding through the NIH,s National Institute of ...l treatments and causes of asthma in urban childre...immunology at UT Southwestern, said continued fund...
(Date:11/22/2009)...urgeon, Dr. Gulani continues to innovate and raise... beyond 20/20.,Known as the Doctor’s Doctor ...blished in teaching LASIK surgeons globally , ...mber 22, 2009 -- Dr. Arun C. Gulani of Gulani Vis...rch as one of the leading Laser Eye Surgeons of th...
(Date:11/22/2009)..., diverse and constant, but inflammation is undesi...San Diego School of Medicine now shows that the no... pathway that prevents excessive inflammation afte...s," said Richard L. Gallo, MD, PhD, professor of m...f Dermatology and the Dermatology section of the V...
Breaking Medicine News(10 mins):Health News:Ophthalmic Equipment Distributor, Latham & Phillips SE Division, Unveils Website 2Health News:Ophthalmic Equipment Distributor, Latham & Phillips SE Division, Unveils Website 3Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 3Health News:UT Southwestern receives continued NIH funding for Inner City Asthma Consortium 2Health News:Dr. Arun Gulani Listed in Forbes Magazine as One of The Leading Laser Eye Surgeons of the United States 2Health News:Surface bacteria maintain skin's healthy balance 2
...wide Healthcare,Communications, a leading advertis...Healthcare Group, received a Gold award at the rec...ation, confirming that their creative,MarketMoving...Sales Aid with their,Ballerina campaign for Alcon ...
... diseases seem to know exactly what types of cells...diseases will inexplicably spare a seemingly ident...le or not depends largely on the kinds and amounts...subtle molecular differences among the hundreds of...
...able in French . , Montreal, November 13, 2008 ...d prostate cancer treatment can foster bone loss. ...Oncology , the scientists explain how loss of bone... , "Our study also looked at possible medication...
... Sending Medical Devices to Market,Faster, PITTSB...,and Quality Solutions, LLC (R&Q Solutions) has la... as the region,s first full-service Regulatory,and...edical equipment and devices industry in the Pitts...
...ologists to discuss benefits and potential ... To satisfy the public,s quest for,younger-lookin...s expanded,dramatically over the years, with littl...the average consumer now has,many choices when it ...
... detecting skin cancer in its earliest ...ased on current estimates, 8,420,people are expect... reverse,this sobering trend, dermatologists and t...d to properly examine their own,skin for signs of ...
Other Medicine News:Health News:Corbett Worldwide Scores Gold at the 2008 MM&M Awards 2Health News:Breakthrough in cell-type analysis offers new ways to study development and disease 2Health News:Breakthrough in cell-type analysis offers new ways to study development and disease 3Health News:Breakthrough in cell-type analysis offers new ways to study development and disease 4Health News:Cancer treatment may result in bone loss 2Health News:R&Q Solutions, LLC Announces Launch to Serve Region's Medical Device Industry 2Health News:R&Q Solutions, LLC Announces Launch to Serve Region's Medical Device Industry 3Health News:Enhanced Cosmetic Procedures Plus New At-Home Treatments Give Patients More Options 2Health News:Enhanced Cosmetic Procedures Plus New At-Home Treatments Give Patients More Options 3Health News:Enhanced Cosmetic Procedures Plus New At-Home Treatments Give Patients More Options 4Health News:Enhanced Cosmetic Procedures Plus New At-Home Treatments Give Patients More Options 5Health News:American Academy of Dermatology: Stop Skin Cancer On The Spot 2Health News:American Academy of Dermatology: Stop Skin Cancer On The Spot 3Health News:American Academy of Dermatology: Stop Skin Cancer On The Spot 4Health News:American Academy of Dermatology: Stop Skin Cancer On The Spot 5Health News:American Academy of Dermatology: Stop Skin Cancer On The Spot 6
(Date:11/20/2009)...RGO, Fla., Nov. 20 Unile...ture Exchange: UVI), which develops, licenses, man...ct lenses, today reported its operating results fo...10). ,, Net sales excluding royalty income, wer...s then $1,761,526 reported in the previous year fi...
(Date:11/20/2009)...HARRISBURG, Pa., Nov. 20 /PRNewswire-USNewswire/ -...ree H1N1 flu shots to members of priority groups t..., A total of 18 clinics are being held statewid...p.m. to 8 p.m. Hours on Saturday, Nov. 21, will be...will operate from 2 p.m. to 8 p.m. ,, Individu...
(Date:11/20/2009)..., NEW YORK, Nov. 20 ,, Reportl...ort is available in its catalogue. ,, Global M...p://www.reportlinker.com/p0164741/Global-Markets-f...wswire&utm_medium=pr&utm_campaign=prnewswi...vices includes the spring loaded core needle marke...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2IU national survey finds majority of Americans believe myths about health care reform 55151 1IU national survey finds majority of Americans believe myths about health care reform 55151 2IU national survey finds majority of Americans believe myths about health care reform 55151 3Researchers find that employees who are engaged in their work have happier home life 55148 1Researchers find that employees who are engaged in their work have happier home life 55148 2Tipping elements remain a hot issue 9683 1Tipping elements remain a hot issue 9683 2Tipping elements remain a hot issue 9683 3
...CISCO, April 14 Positive preclinical,data was pre...s week for its,lead oncolytic candidate, NKTR-102 ...-tumor activity in a mouse xenograft model of colo...b. Presented at the American,Association for Cance...,California, the data also featured the enhanced p...
... Calif., April 14 Kosan Biosciences,Incorporated ...trial of,epothilone KOS-1584 in patients with non-...se 2 trial is an open-label, multi-center, monothe... advanced or metastatic,non-small cell lung cancer...therapy regimen. The primary endpoint of the Phase...
Other Medicine Technology:Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 2Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 3Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 4Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 5Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer 2Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer 3Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer 4
Data Trol™ Normal Control Serum
AdvancedMD Medical Claims Billing
Managed Care
Visionary OFFICE™ PM Billing
Medicine Products: